2016-09-03T08:14:56-05:00 2015-12-31 362985770 SELDEN FOX LTD 619 ENTERPRISE DRIVE OAK BROOK IL 605238835 990 2015-01-01 043809491 CLINICAL RESEARCH FORUM INC CLIN 2023671176 2025 M STREET NW NO 800 WASHINGTON DC 20036 WILLIAM LOWE TREASURER 2023671176 2016-08-10 1 ROBERT G WUJEK P01367472 6309541400 2015 2016-12-15 16:53:06Z X HARRY P SELKER 2025 M STREET NW NO 800 WASHINGTON DC 20036 608446 0 X WWW.CLINICALRESEARCHFORUM.ORG X 2005 DE PROVIDE LEADERSHIP TO THE NATIONAL CLINICAL AND TRANSLATIONAL RESEARCH ENTERPRISE AND PROMOTE UNDERSTANDING AND SUPPORT FOR CLINICAL RESEARCH AND ITS IMPACT ON HEALTH AND HEALTHCARE. 15 15 0 17 0 0 469900 458144 52650 108745 22377 26266 0 0 544927 593155 0 13161 0 0 76076 0 0 0 0 449624 456224 525700 469385 19227 123770 1109230 821406 432172 60230 677058 761176 X PROVIDE LEADERSHIP TO THE NATIONAL CLINICAL AND TRANSLATIONAL RESEARCH ENTERPRISE AND PROMOTE UNDERSTANDING AND SUPPORT FOR CLINICAL RESEARCH AND ITS IMPACT ON HEALTH AND HEALTHCARE. 0 0 68887 13161 0 TOP TEN CLINCIAL RESEARCH ADVANCEMENT AWARDS - THE FORUM'S TOP TEN CLINICAL RESEARCH ACHIEVEMENT AWARDS HONOR OUSTANDING ACCOMPLISHMENTS IN CLINICAL RESEARCH, THROUGH AN ANNUAL COMPETITION SEEKING TO IDENTIFY MAJOR ADVANCES RESULTING FROM THE NATION'S INVESTMENT IN RESEARCH TO BENEFIT THE HEALTH AND WELFARE OF ITS CITIZENS. SELECTION CRITERIA USED TO DETERMINE THE AWARD WINNERS INCLUDE: (A) THE DEGREE OF INNOVATION AND CREATIVITY INVOLVED AND ITS ADVANCEMENT OF THE SCIENCE IN A SPECIFIC AREA (B) THE CONTRIBUTION TO THE UNDERSTANDING OF HUMAN DISEASE AND/OR HUMAN PHYSIOLOGY AND (C) THE POTENTIAL IMPACT UPON THE DIAGNOSIS, PREVENTION AND/OR TREATMENT OR INCREASED UNDERSTANDING OF THE DISEASE STATE. 52126 0 76045 IT ROUNDTABLE - THE FORUM CONSIDERS THE INTEGRATION OF INFORMATION TECHNOLOGY (IT) AND CLINICAL RESEARCH A HIGH PRIORITY FOR ITS MEMBERS. ROUNDTABLE MEETINGS PROVIDE A VENUE FOR ACADEMIC HEALTH CENTER LEADERS TO SHARE EXPERIENCES AND WORK WITH VENDORS TO ADDRESS KEY IT ISSUES IN CLINCIAL RESEARCH, SUCH AS THE INTERFACE OF CLINICAL SERVICES AND CLINICAL RESEARCH DATA, WAREHOUSING, DATA SECURITY, ELECTRONIC HEALTH RECORD PLATFORMS, AND GOVERNANCE. 44651 0 16200 ANNUAL MEETING - THE FORUM CONDUCTS AN ANNUAL MEETING TO BRING TOGETHER ALLO OF THE DISCIPLINGS INVOLVED IN CLINCIAL AND TRANSLATIONAL RESEARCH FOR THE SHARED BENEFITS OF NETWORKING AND EDUCATION WITHE GOAL TO (A) INSPIRE PARTICIPANTS BY IDENTIFYING THE GREAT SUCCESSES OF CLINICAL AND TRANSLATIONAL RESEARCH AND DESCRIBING HOW THEY HAVE IMPROVED THE LIVES OF SO MANY PEOPLE (B) PROVIDE PARTICIPANTS WITH THE NEWEST AND MOST VALUABLE INFORMATION IN CLINICAL AND TRANSLATIONAL SCIENCE (C) PROVIDE TRAINEES AND ALL MEETING PARTICIPANTS AN OPPORTUNITY TO PRESENT THEIR RESEARCH TO A SUPPORTIVE GROUP OF THEIR PEERS, EDUCATORS, AND SENIOR INVESTIGATORS (D)COMMUNICATE NOVEL METHODS, BEST PRACTICES, AND RESOURCES FOR CLINICAL TRANSLATION (E) PROVIDE EXCITING AND DYNAMIC CAREER DEVELOPMENT PROGRAMS FOR TRAINEES AND THEIR MENTORS AND (F) PROVIDE EDUCATORS A VENUE TO PRESENT BEST PRACTICES IN CLINICAL AND TRANSLATIONAL RESEARCH CAREER DEVELOPMENT. 25678 0 0 ADVOCACY - THE FORUM IS A MEMBER OF THE COALITION FOR CLINICAL & TRANSLATIONAL SCIENCE (CCTS), WHICH IS THE UNIFIED VOICE OF THE CLINCIAL AND TRANSLATIONAL SCIENCE RESEARCH COMMUNITY. CCTS IS A NATIONWIDE GRASSROOTS NETWORK OF DEDICATED INDIVIDUALS WHO WORK TOGETHER TO EDUCATE CONGRESS AND THE ADMINISTRATION ABOUT THE VALUE AND IMPORTANCE OF FEDERAL CLINICAL AND TRANSLATIONAL RESEARCH AND RESEARCH TRAINING AND CAREER DEVELOPMENT ACTIVITIES. CCTS WORKS TO ENSURE THE (A) FULL SPECTRUM OF MEDICAL RESEARCH IS ADEQUATELY FUNDED, (B) NEXT GENERATION OF RESEARCHERS IS WELL-PREPARED, AND (C) REGULATORY AND PUBLIC POLICY ENVIRONMENT FACILITATES ONGOING EXPANSION AND ADVANCEMENT OF THE FIELD OF CLINICAL AND TRANSLATIONAL SCIENCE. 272 0 16500 INDUSTRY ROUNDTABLE - THE FORUM SPONSORS AN INDUSRY ROUNDTABLE TO DISCUSS THE CHALLENGES FACING CLINICAL RESEARCH, AND THE APPROACHES THAT MIGHT BE FOLLOWED TO CREATE A MORE SUPPORTING ENVIRONMENT FOR THE CONDUCT OF A BROAD AGENDA OF HIGH QUALITY CLINICAL RESEARCH. 4358 0 0 PATIENT ADVOCACY INITIATIVE - THE FORUM SPONSORED A SURVEY AND WHITE PAPER IN COLLABORATION WITH KEY VOLUNTEER HEALTH ASSOCIATIONS AND PATIENT GROUPS TO IDENIFY MUTUAL INTERESTS AND DEVELOP A PATHWAY FOR PARTNERING IN THE FUTURE. 30308 0 16500 195972 0 1 0 1 0 0 0 0 0 0 1 0 0 0 1 0 1 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 1 4 0 1 0 0 0 0 0 1 1 0 0 0 X 15 15 0 1 0 0 0 1 1 1 1 0 0 1 1 1 1 1 1 0 0 0 X SMITHBUCKLIN CORPORATION 2023671176 2025 M STREET NW SUITE 800 WASHINGTON DC 20036 X HARRY P SELKER CHAIRMAN 4.00 X X 0 0 0 HERBERT PARDES VICE CHAIRMAN 3.00 X X 0 0 0 WILLIAM L LOWE TREASURER 2.00 X X 0 0 0 LARS BERGLUND DIRECTOR 1.00 X 0 0 0 BARRY S COLLER DIRECTOR 1.00 X 0 0 0 ANNE B CURTIS DIRECTOR 1.00 X 0 0 0 PAMELA DAVIS DIRECTOR 1.00 X 0 0 0 MAURIZIO FAVA DIRECTOR 1.00 X 0 0 0 HARRY B GREENBERG DIRECTOR 1.00 X 0 0 0 REBECCA D JACKSON DIRECTOR 1.00 X 0 0 0 ERIC PETERSON DIRECTOR 1.00 X 0 0 0 E ALBERT REECE DIRECTOR 1.00 X 0 0 0 ARTHUR H RUBENSTEIN DIRECTOR 1.00 X 0 0 0 ROBERT SHERWIN DIRECTOR 1.00 X 0 0 0 ALASTAIR J J WOOD DIRECTOR 1.00 X 0 0 0 DANIEL E FORD EX OFFICIO 1.00 X 0 0 0 ANANTHA SHEKHAR EX OFFICIO 1.00 X 0 0 0 ANDRE WILLIAMS EXECUTIVE DIRECTOR 40.00 X 0 0 0 0 0 0 0 0 0 0 SMITHBUCKLIN CORPORATION 330 N WABASH AVENUE CHICAGO IL 60611 MANAGEMENT 144524 1 449200 8944 8944 458144 IT ROUNDTABLE 900099 76045 76045 INDUSTRY ROUNDTABLE 900099 16500 16500 ANNUAL MEETING 900099 16200 16200 108745 19749 19749 21808 15291 6517 6517 6517 593155 108745 0 26266 13161 13161 283879 75521 208358 1195 1195 18500 18500 11958 11958 5430 5430 30000 30000 24024 2736 21288 3219 332 2887 3142 3142 19016 15492 3524 46627 46497 130 5702 5702 BANK & CREDIT CARD FEES 3532 275 3257 469385 195972 273413 0 684556 422457 3965 2057 418253 396892 2456 0 1109230 821406 195472 1190 236700 44000 0 15040 432172 60230 X 594998 672510 82060 88666 677058 761176 1109230 821406 123770 -39652 0 X X 0 1 X 1 0 RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED 1 0 0 96948 -3282 5000 88666 98895 0 3053 5000 96948 93562 0 10333 5000 98895 0 97060 1502 5000 93562 1.00000 0 0 0 MUTUAL FUNDS 396892 F 396892 DUE TO CLINICAL RESEARCH FOUNDATION, INC. 15040 15040 X 548073 -39652 -39652 587725 5430 5430 593155 464080 125 125 463955 5430 5430 469385 PART V, LINE 4: IN 2012, AN ENDOWMENT FUND WAS ESTABLISHED TO PROVIDE A $5,000 ANNUAL AWARD TO RECONGIZE EXCELLENCE IN THE CLINICAL RESEARCH FIELD. PRIOR TO 2015, THE AMOUNT WAS NOT REPORTED AS AN ENDOWMENT. IN 2015, SCHEDULE D WAS ADJUSTED TO REFLECT THE ACTIVITY IN THE ENDOWMENT SINCE ITS INCEPTION. PART X, LINE 2: THE FORUM HAS DETERMINED THEY ARE NOT REQUIRED TO RECORD A LIABILITY FOR ANY UNCERTAIN TAX POSITIONS. PART XII, LINE 2D - OTHER ADJUSTMENTS: EXPENSES OF CLINICAL RESEARCH FORUM FOUNDATION, INC. INCLUDED IN CONSOLIDATED FINANCIAL STATEMENTS 125. 1 CLINICAL RESEARCH AWARDS 3 12000 0 CASH AWARDED PART I, LINE 2: EACH YEAR NOMINATIONS ARE REQUESTED FOR THE FORUM'S TOP TEN CLINICAL RESEARCH ACHIEVEMENT AWARDS. BASED ON THE ELIGIBLE NOMINATIONS, THE TOP 20 ARE IDENTIFIED. THE LIST IS THEN NARROWED TO THE TOP 10 AND A FINAL REVIEW IDENTIFIES THE TOP 3 WINNERS WHO WILL RECEIVE MONETARY PRIZES. THE FORUM'S BOARD OF DIRECTORS SERVES AS THE SELECTION COMMITTEE, WITH THE SELECTION CRITERIA BASED ON 1) THE DEGREE OF INNOVATION AND CREATIVITY INVOLVED AND ITS ADVANCEMENT OF THE SCIENCE IN A SPECIFIC AREA, 2) CONTRIBUTION TO THE UNDERSTANDING OF HUMAN DISEASE AND/OR HUMAN PHYSIOLOGY, AND 3) POTENTIAL IMPACT UPON THE DIAGNOSIS, PREVENTION, AND/OR TREATMENT OR INCREASED UNDERSTANDING OF THE DISEASE STATE. FORM 990, PART VI, SECTION A, LINE 3 THE FORUM HAS DELEGATED THE MANAGEMENT OF ITS DAILY OPERATIONS TO SMITHBUCKLIN CORPORATION. SMITHBUCKLIN CORPORATION IS A MANAGEMENT COMPANY WHICH MANAGES ALL ASPECTS OF THE ASSOCIATION IN ACCORDANCE WITH THE ASSOCIATION'S BYLAWS AND POLICIES. OPERATIONS MAY INCLUDE, BUT ARE NOT LIMITED TO, ADMINISTRATION, MEMBERSHIP, FINANCE AND ACCOUNTING, CONVENTION/TRADESHOW/MEETING PLANNING, EDUCATION, MARKETING, INFORMATION TECHNOLOGY AND GOVERNMENT RELATIONS. SMITHBUCKLIN CORPORATION EMPLOYEES PROVIDE THESE SERVICES. FORM 990, PART VI, SECTION A, LINE 7A PER THE BYLAWS OF THE ORGANIZATION, EACH DUES-PAYING ACADEMIC HEALTH CENTER MEMBER MAY CAST ONE VOTE FOR THE ANNUAL ELECTION OF THE BOARD OF DIRECTORS. A SLATE OF CANDIDATES IS PREPARED BY THE NOMINATING COMMITTEE AND APPROVED BY THE BOARD OF DIRECTORS. A BALLOT IS THEN DISTRIBUTED TO THE MEMBERSHIP FOR VOTING. A MAJORITY OF THE VOTING MEMBERS IS REQUIRED TO ELECT NEW DIRECTORS. FORM 990, PART VI, SECTION A, LINE 7B PER THE BYLAWS OF THE ORGANIZATION, ALL GOVERNANCE AND CHANGES TO THE BYLAWS ARE PRESENTED TO THE MEMBERSHIP AT THE ANNUAL MEMBERS MEETING IN APRIL. A MAJORITY OF ACADEMIC HEALTH CENTER VOTES IS REQUIRED TO APPROVE ANY CHANGES. FORM 990, PART VI, SECTION B, LINE 11 FORM 990 IS REVIEWED BY MANAGEMENT AND THE BOARD'S FINANCE AND AUDIT SUBCOMMITTEE PRIOR TO FILING WITH THE IRS. FORM 990, PART VI, SECTION B, LINE 12C BOARD MEMBERS ARE REQUIRED TO COMPLETE AND SUBMIT A QUESTIONNAIRE AND STATEMENT OF DISCLOSURE ANNUALLY. THEY ARE REQUIRED TO INFORM THE AUDIT COMMITTEE IF THERE IS ANY CHANGE OR IF A CONFLICT ARISES DURING THE YEAR. THE AUDIT COMMITTEE REVIEWS EACH QUESTIONNAIRE AND DISCLOSURE STATEMENT OR ANY SET OF FACTS OR CIRCUMSTANCES THAT MAY REFLECT AN ACTUAL, POTENTIAL, OR APPARENT CONFLICT OF INTEREST. THE AUDIT COMMITTEE MAY REQUEST THE ASSISTANCE OF LEGAL COUNSEL TO IDENTIFY POTENTIAL CONFLICTS. THE AUDIT COMMITTEE MAY ASK FOR ADDITIONAL INFORMATION. THE AUDIT COMMITTEE MAKES RECOMMENDATIONS TO THE BOARD TO EITHER WAIVE THE CONFLICT OR ASK THE DIRECTOR TO RESIGN. THE BOARD OF DIRECTORS HAS THE FINAL DECISION ON THE RECOMMENDATIONS. FORM 990, PART VI, SECTION C, LINE 19 THE FORUM'S GOVERNING DOCUMENTS, CONFLICT OF INTEREST POLICY, AND YEAR END FINANCIAL STATEMENTS ARE AVAILABLE TO MEMBERS AND REVIEWED AT THE ANNUAL MEMBERS' MEETING. THIS INFORMATION IS ALSO AVAILABLE TO THE GENERAL PUBLIC UPON REQUEST. CLINICAL RESEARCH FOUNDATION INC 2025 M STREET NW SUITE 800 WASHINGTON DC 20036 020773588 TO PROVIDE LEADERSHIP TO THE NATIONAL CLINIC DE 501(C)(3) LINE 7 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 1